Prospectively measured triiodothyronine levels are positively associated with breast cancer risk in postmenopausal women
Open Access
- 11 June 2010
- journal article
- Published by Springer Science and Business Media LLC in Breast Cancer Research
- Vol. 12 (3), R33
- https://doi.org/10.1186/bcr2587
Abstract
The potential association between hypo- and hyperthyroid disorders and breast cancer has been investigated in a large number of studies during the last decades without conclusive results. This prospective cohort study investigated prediagnostic levels of thyrotropin (TSH) and triiodothyronine (T3) in relation to breast cancer incidence in pre- and postmenopausal women.Keywords
This publication has 52 references indexed in Scilit:
- Influence of thyroid hormone receptors on breast cancer cell proliferationAnnals Of Oncology, 2005
- Management of the nontoxic multinodular goitre: A European questionnaire studyClinical Endocrinology, 2000
- Serum Thyroid Peroxidase Autoantibodies, Thyroid Volume, and Outcome in Breast CarcinomaJournal of Clinical Endocrinology & Metabolism, 1998
- Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancyJournal of Clinical Endocrinology & Metabolism, 1996
- Benign Thyroid Diseases and the Risk of Death from Breast CancerOncology, 1992
- Breast cancer risk and history of selected medical conditions linked with female hormonesEuropean Journal of Cancer and Clinical Oncology, 1990
- Thyroid function in patients with breast cancerEuropean Journal of Cancer and Clinical Oncology, 1987
- Thyroid function in women with breast cancerEuropean Journal of Cancer and Clinical Oncology, 1986
- Relationship of thyroid disease and use of thyroid supplements to breast cancer riskJournal of Chronic Diseases, 1984
- Thyroid disease and breast cancer: Findings in a large case-control studyBritish Journal of Surgery, 1982